Ragheb Al-Shakhshir

Title: Ragheb Al-Shakhshir: Innovator in Pharmaceutical Formulations

Introduction

Ragheb Al-Shakhshir is a notable inventor based in Bedford, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations for parenteral administration of fentanyl. With a total of 2 patents to his name, Al-Shakhshir's work is crucial for improving patient care.

Latest Patents

Al-Shakhshir's latest patents focus on ready-to-administer fentanyl formulations. These stable liquid formulations include fentanyl or a pharmaceutically acceptable salt thereof. The formulations consist of a diluent and buffer, which may contain sodium, in an aqueous solution with a pH ranging from about 3 to about 4.5. These parenteral liquid formulations are designed to be stable and are supplied as ready-to-administer products in infusion containers or bags. They undergo terminal sterilization in the infusion container, ensuring their suitability for administration to patients requiring therapy with fentanyl or its salts.

Career Highlights

Ragheb Al-Shakhshir is associated with Hikma Pharmaceuticals International Limited, a company known for its commitment to providing high-quality pharmaceutical products. His work at Hikma has allowed him to focus on innovative solutions that enhance the safety and efficacy of drug delivery systems.

Collaborations

Al-Shakhshir has collaborated with notable colleagues, including Andrew Conrad and Ragheb AbuRmaileh. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Ragheb Al-Shakhshir's contributions to pharmaceutical innovations, particularly in fentanyl formulations, highlight his role as a key inventor in the industry. His work not only advances medical science but also improves patient outcomes through safer drug administration methods.